Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sara Redaelli

Showing results (21-30 of 34) with videos related to

Pageof 4
Sort By:
Plos One|December 6, 2011
ERG deregulation induces PIM1 over-expression and aneuploidy in prostate epithelial cellsVera Magistroni, Luca Mologni, Stefano Sanselicio, et al.
Journal of Molecular Endocrinology|October 13, 2006
Inhibition of RET tyrosine kinase by SU5416Luca Mologni, Elisa Sala, Sara Cazzaniga, et al.
Cancer Research|October 17, 2018
Lorlatinib Treatment Elicits Multiple On- and Off-Target Mechanisms of Resistance in ALK-Driven CancerSara Redaelli, Monica Ceccon, Marina Zappa, et al.
Oncotarget|August 22, 2015
Non genomic loss of function of tumor suppressors in CML: BCR-ABL promotes IκBα mediated p53 nuclear exclusionSabrina Crivellaro, Cristina Panuzzo, Giovanna Carrà, et al.
Cancer Research|November 23, 2006
In vitro and in vivo activity of SKI-606, a novel Src-Abl inhibitor, against imatinib-resistant Bcr-Abl+ neoplastic cellsMiriam Puttini, Addolorata Maria Luce Coluccia, Frank Boschelli, et al.
Haematologica|March 28, 2008
Characterization of compound 584, an Abl kinase inhibitor with lasting effectsMiriam Puttini, Sara Redaelli, Loris Moretti, et al.
Cancers|September 10, 2021
Synergistic Drug Combinations Prevent Resistance in ALK+ Anaplastic Large Cell LymphomaGiulia Arosio, Geeta G Sharma, Matteo Villa, et al.
Blood|June 1, 2007
NPM/ALK binds and phosphorylates the RNA/DNA-binding protein PSF in anaplastic large-cell lymphomaAnnamaria Galietta, Rosalind H Gunby, Sara Redaelli, et al.
Journal of the National Cancer Institute|February 5, 2014
Crizotinib in advanced, chemoresistant anaplastic lymphoma kinase-positive lymphoma patientsCarlo Gambacorti Passerini, Francesca Farina, Alessandra Stasia, et al.
Nature Communications|June 8, 2018
SETBP1 induces transcription of a network of development genes by acting as an epigenetic hubRocco Piazza, Vera Magistroni, Sara Redaelli, et al.
Pageof 4

Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
Plos One|December 6, 2011
ERG deregulation induces PIM1 over-expression and aneuploidy in prostate epithelial cellsVera Magistroni, Luca Mologni, Stefano Sanselicio, et al.
Journal of Molecular Endocrinology|October 13, 2006
Inhibition of RET tyrosine kinase by SU5416Luca Mologni, Elisa Sala, Sara Cazzaniga, et al.
Cancer Research|October 17, 2018
Lorlatinib Treatment Elicits Multiple On- and Off-Target Mechanisms of Resistance in ALK-Driven CancerSara Redaelli, Monica Ceccon, Marina Zappa, et al.
Oncotarget|August 22, 2015
Non genomic loss of function of tumor suppressors in CML: BCR-ABL promotes IκBα mediated p53 nuclear exclusionSabrina Crivellaro, Cristina Panuzzo, Giovanna Carrà, et al.
Cancer Research|November 23, 2006
In vitro and in vivo activity of SKI-606, a novel Src-Abl inhibitor, against imatinib-resistant Bcr-Abl+ neoplastic cellsMiriam Puttini, Addolorata Maria Luce Coluccia, Frank Boschelli, et al.
Haematologica|March 28, 2008
Characterization of compound 584, an Abl kinase inhibitor with lasting effectsMiriam Puttini, Sara Redaelli, Loris Moretti, et al.
Cancers|September 10, 2021
Synergistic Drug Combinations Prevent Resistance in ALK+ Anaplastic Large Cell LymphomaGiulia Arosio, Geeta G Sharma, Matteo Villa, et al.
Blood|June 1, 2007
NPM/ALK binds and phosphorylates the RNA/DNA-binding protein PSF in anaplastic large-cell lymphomaAnnamaria Galietta, Rosalind H Gunby, Sara Redaelli, et al.
Journal of the National Cancer Institute|February 5, 2014
Crizotinib in advanced, chemoresistant anaplastic lymphoma kinase-positive lymphoma patientsCarlo Gambacorti Passerini, Francesca Farina, Alessandra Stasia, et al.
Nature Communications|June 8, 2018
SETBP1 induces transcription of a network of development genes by acting as an epigenetic hubRocco Piazza, Vera Magistroni, Sara Redaelli, et al.
Pageof 4